Mindmed is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. We spoke with co-CEO JR Rahn about his path as an entrepreneur, the company’s approach to tackling the opioid crisis and their intellectual property strategy.
Learn more about MindMed at their website: https://www.mindmed.co/
Stay up to date with the latest in the business of psychedelics by subscribing to our weekly briefing: https://reportonpsychedelics.com/#briefing-signup
Our Conversations Podcast is supported by the NEO Exchange. With a focus on fairness, liquidity, efficiency and unparalleled client service, the NEO Exchange creates a better public listing experience by doing what’s right for investors and capital-raisers. Learn why NEO is the next generation stock exchange at neostockexchange.com.